Subcellular localization of apurinic endonuclease 1 promotes lung tumor aggressiveness via NF-κB activation

Oncogene

Volumn 29, Issue 30, 2010, Pages 4330-4340

  Wu, H H ^a   Cheng, Y W ^a   Chang, J T ^a   Wu, T C ^b   Liu, W S ^b   Chen, C Y ^c   Lee, H ^a,d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Cox 2; cytoplasmic Ape1; lung tumor metastasis; NF B

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; APURINIC ENDONUCLEASE 1; CISPLATIN; COMPLEMENTARY DNA; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PLASMID DNA; REDOX EFFECTOR FACTOR 1; RESVERATROL; SULFATHALAZINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; MULTIVARIATE ANALYSIS; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT RESPONSE; TUMOR RECURRENCE; UNIVARIATE ANALYSIS;

ANIMALS; CELL NUCLEUS; CYCLOOXYGENASE 2; CYTOPLASM; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NF-KAPPA B; PROGNOSIS; TRANSCRIPTION FACTOR RELA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77955174568     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.178     Document Type: Article

References (46)

1. Aggarwal BB. (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208.
2. Ando K, Hirao S, Kabe Y, Ogura Y, Sato I, Yamaguchi Y et al. (2008). A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity. Nucl Acids Res 36: 4327-4336.
3. Angkeow P, Deshpande SS, Qi B, Liu YX, Park YC, Jeon BH et al. (2002). Redox factor-1: an extra-nuclear role in the regulation of endothelial oxidative stress and apoptosis. Cell Death Differ 9: 717-725.
4. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR et al. (2007). Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 224: 274-283.
5. Bapat A, Fishel ML, Kelley MR. (2008). Going Ape1 as approach to cancer therapy. Antoxid Redox Signal 11: 651-668.
6. Bhakat KK, Mantha AK, Mitra S. (2009). Transcriptional regulatory functions of mammalian AP-endonuclease (APE/Ref-1), an essential multifunctional protein. Antioxid Redox Signal 11: 1-19.
7. Busso CS, Iwakuma T, Izumi T. (2009). Ubiquitination of mammalian AP endonuclease (APE1) regulated by the p53-MDM2 signaling pathway. Oncogene 28: 1616-1625.
8. Chen G, Bhojani MS, Heaford AC, Chang DC, Laxman B, Thomas DG et al. (2005). Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas. Proc Natl Acad Sci USA 102: 12507-12512.
9. Cheng YW, Wu MF, Wang J, Yeh KT, Goan YG, Chiou HL et al. (2004). Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res 67: 10686-10693.
10. Delhase M, Hayakawa M, Chen Y, Karin M. (1999). Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284: 309-313.
11. Dey A, Tergaonkar V, Lane DP. (2008). Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways. Nat Rev Drug Discov 7: 1031-1040.
12. Di Maso V, Avellini C, Croce LS, Rosso N, Quadrifoglio F, Cesaratto L et al. (2007). Subcellular localization of APE1/Ref-1 in human hepatocellular carcinoma: possible prognostic significance. Mol Med 13: 89-96.
13. Fantini D, Vascotto C, Deganuto M, Bivi N, Gustincich S, Marcon G et al. (2008). APE1/Ref-1 regulates PTEN expression mediated by Egr-1. Free Radic Res 42: 20-29.
14. Freitas S, Moore DH, Michael H, Kelley MR. (2003). Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer: correlations with tumor progression and platinum resistance. Clin Cancer Res 9: 4689-4694.
15. Gaiddon C, Moorthy NC, Prives C. (1999). Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J 18: 5609-5621.
16. Huang LE, Arany Z, Livingston DM, Bunn HF. (1996). Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 271: 32253-32259.
17. Jackson EB, Theriot CA, Chattopadhyay R, Mitra S, Izumi T. (2005). Analysis of nuclear transport signals in the human apurinic/apyrimidinic endonuclease (APE1/Ref1). Nucleic Acids Res 33: 3303-3312.
18. Jiang Y, Cui L, Yie TA, Rom WN, Cheng H, Tchou-Wong KM. (2001). Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by IkappaBbeta. Oncogene 20: 2254-2263.
19. Kakolyris S, Giatromanolaki A, Koukourakis M, Kaklamanis L, Kanavaros P, Hickson ID et al. (1999). Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC). J Pathol 189: 351-357.
20. Kakolyris S, Kaklamanis L, Giatromanolaki A, Koukourakis M, Hickson ID, Barzilay G et al. (1998). Expression and subcellular localization of human AP endonuclease 1 (HAP1/Ref-1) protein: a basis for its role in human disease. Histopathology 33: 561-569.
21. Karin M. (2006). Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436.
22. Kelly JW. (2000). Mechanisms of amyloidogenesis. Nat Struct Biol 7: 824-826.
23. Liu J, Zhan M, Hannay JA, Das P, Bolshakov SV, Kotilingam D et al. (2006). Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis. Mol Cancer Res 4: 803-810.
24. Maeda S, Omata M. (2008). Inflammation and cancer: role of nuclear factor-kappaB activation. Cancer Sci 99: 836-842.
25. Moore DH, Michael H, Tritt R, Parsons SH, Kelley MR. (2000). Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers. Clin Cancer Res 6: 602-609.
26. Nishi T, Shimizu N, Hiramoto M, Sato I, Yamaguchi Y, Hasegawa M et al. (2002). Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo. J Biol Chem 277: 44548-44556.
27. Pines A, Perrone L, Bivi N, Romanello M, Damante G, Gulisano M et al. (2005). Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. Nucleic Acids Res 33: 4379-4394.
28. Puglisi F, Aprile G, Minisini AM, Barbone F, Cataldi P, Tell G et al. (2001). Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomas. Anticancer Res 21: 4041-4049.
29. Puglisi F, Barbone F, Tell G, Aprile G, Pertoldi B, Raiti C et al. (2002). Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas. Oncol Rep 9: 11-17.
30. Qu J, Liu GH, Huang B, Chen C. (2007). Nitric oxide controls nuclear export of APE1/Ref-1 through S-nitrosation of cysteines 93 and 310. Nucleic Acids Res 35: 2522-2532.
31. Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM. (2005). The antioxidant function of the p53 tumor suppressor. Nat Med 11: 1306-1313.
32. Shimizu N, Sugimoto K, Tang J, Nishi T, Sato I, Hiramoto M et al. (2000). High-performance affinity beads for identifying drug receptors. Nat Biotechnol 18: 877-881.
33. Stathopoulos GT, Sherrill TP, Cheng DS, Scoggins RM, Han W, Polosukhin VV et al. (2007). Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis. Proc Natl Acad Sci USA 104: 18514-18519.
34. Stathopoulos GT, Sherrill TP, Han W, Sadikot RT, Yull FE, Blackwell TS et al. (2008). Host nuclear factor-kappaB activation potentiates lung cancer metastasis. Mol Cancer Res 6: 364-371.
35. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S. (1995). Ikappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell 80: 573-582.
36. Tang X, Liu D, Shishodia S, Ozburn N, Behrens C, Lee JJ et al. (2006). Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions. Cancer 107: 2637-2646.
37. Tell G, Damante G, Caldwell D, Kelly MR. (2009). The intracellular localization of APE/Ref-1: more than a passive phenomenon. Antioxid Redox Signal 11: 1-19.
38. Tell G, Quadrifoglio F, Tiribelli C, Kelly MR. (2009). The many functions of APE/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 11: 1-19.
39. Van Waes C. (2007). Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin Cancer Res 13: 1076-1082.
40. Weisz L, Damalas A, Liontos M, Karakaidos P, Fontemaggi G, Maor-Aloni R et al. (2007). Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells. Cancer Res 67: 2396-2401.
41. Wu C, Ghosh S. (2003). Differential phosphorylation of the signal-responsive domain of I kappa B alpha and I kappa B beta by I kappa B kinases. J Biol Chem 278: 31980-31987.
42. Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD. (2006). Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat Cell Biol 8: 398-406.
43. Xu Y, Moore DH, Broshears J, Liu L, Wilson TM, Kelley MR. (1997). The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer. Anticancer Res 17: 3713-3719.
44. Yang S, Irani K, Heffron SE, Jurnak F, Meyskens Jr FL. (2005). Alterations in the expression of the apurinic/apyrimidinic endo-nuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor. Mol Cancer Ther 4: 1923-1935.
45. Yang Z, Yang S, Misner BJ, Chiu R, Liu F, Meyskens Jr FL. (2008). Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol. Mol Cancer Ther 7: 3751-3760.
46. Zaky A, Busso C, Izumi T, Chattopadhyay R, Bassiouny A, Mitra S et al. (2008). Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage. Nucleic Acids Res 36: 1555-1566.